BioSig Technologies, Inc. (BSGM)

BioSig Technologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	0.02	0.29	0.44	0	0
Revenue Growth (YoY)	-93.71%	-35.15%	-	-	-
Cost of Revenue	0.36	0.06	0.2	0.55	0.05
Gross Profit	-0.34	0.23	0.24	-0.55	-0.05
Selling, General & Admin	23.08	21.38	27.85	40.95	24.81
Research & Development	5.09	5.82	5.6	18.14	9.74
Other Operating Expenses	-0.19	0.29	0.2	0.09	0.05
Operating Expenses	28.53	27.49	33.65	59.18	34.6
Operating Income	-28.51	-27.27	-33.41	-59.18	-34.6
Interest Income	0.01	0	0	0.05	0.13
Interest Expense	0	-0	0	0	0
Other Expense / Income	0.18	0	-0.55	0	-0
Pretax Income	-28.69	-27.26	-32.86	-59.14	-34.47
Income Tax	0.36	0.01	-1.49	-6.97	-0.55
Net Income	-29.04	-27.27	-31.36	-52.17	-33.92
Shares Outstanding (Basic)	7	4	3	3	2
Shares Outstanding (Diluted)	7	4	3	3	2
Shares Change	70.68%	28.53%	20.09%	34.85%	42.68%
EPS (Basic)	-3.95	-6.33	-9.36	-18.70	-16.39
EPS (Diluted)	-3.95	-6.33	-9.36	-18.70	-16.39
Free Cash Flow	-17.5	-21.87	-26.94	-26.69	-15.77
Free Cash Flow Per Share	-2.38	-5.08	-8.04	-9.56	-7.62
Gross Margin	-1905.56%	80.07%	54.88%	-	-
Operating Margin	-158400.00%	-9533.22%	-7576.19%	-	-
Profit Margin	-161338.89%	-9535.31%	-7111.56%	-	-
Free Cash Flow Margin	-97216.67%	-7647.90%	-6109.07%	-	-
EBITDA	-28.15	-26.97	-33.77	-58.63	-34.55
EBITDA Margin	-156394.44%	-9430.77%	-7656.69%	-	-
Depreciation & Amortization	0.36	0.29	0.2	0.55	0.05
EBIT	-28.51	-27.27	-33.96	-59.18	-34.6
EBIT Margin	-158400.00%	-9533.22%	-7701.59%	-	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.